|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2000034357 |
|
最近更新日期: Date of Last Refreshed on: |
2020-07-04 11:19:32 |
|
注册时间: Date of Registration: |
2020-07-04 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
磁共振扩散峰度成像在学龄前孤独症儿童脑部的应用研究 |
|
Public title: |
Application of diffusion kurtosis imaging in the brain of preschool children with autism |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
磁共振扩散峰度成像在学龄前孤独症儿童脑部的应用研究 |
|
Scientific title: |
Application of diffusion kurtosis imaging in the brain of preschool children with autism |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
唐世龙 |
研究负责人: |
唐世龙 |
|
Applicant: |
Shilong Tang |
Study leader: |
Shilng Tang |
|
申请注册联系人电话: Applicant telephone: |
+86 13018391877 |
研究负责人电话: Study leader's telephone: |
+86 13018391877 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
sltang66@163.com |
研究负责人电子邮件: Study leader's E-mail: |
sltang66@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
重庆市渝中区中山二路136号 |
研究负责人通讯地址: |
重庆市渝中区中山二路136号 |
|
Applicant address: |
136 Second Zhongshan Road, Yuzhong District, Chongqing, China |
Study leader's address: |
136 Second Zhongshan Road, Yuzhong District, Chongqing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
400016 |
研究负责人邮政编码: Study leader's postcode: |
400016 |
|
申请人所在单位: |
重庆医科大学附属儿童医院 |
||
|
Applicant's institution: |
Children’s Hospital of Chongqing Medical University |
||
|
研究负责人所在单位: |
重庆医科大学附属儿童医院 |
||
|
Affiliation of the Leader: |
Children’s Hospital of Chongqing Medical University |
||
|
是否获伦理委员会批准: |
否/No |
||
|
Approved by ethic committee: |
No |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦理委员会批件附件: Approved file of Ethical Committee: |
||
|
批准本研究的伦理委员会名称: |
|
||
|
Name of the ethic committee: |
|
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 |
||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
重庆医科大学附属儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Children’s Hospital of Chongqing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
重庆市渝中区中山二路136号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
136 Second Zhongshan Road, Yuzhong District, Chongqing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Raise independently |
||||||||||||||||||||||
|
Target disease: |
autism |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
析因分组(即根据危险因素或暴露因素分组) |
||||||||||||||||||||||
|
Study design: |
Factorial |
||||||||||||||||||||||
|
研究目的: |
本研究通过对ASD病患儿和年龄相对应正常儿童进行磁共振常规序列、3D T1 、DKI等序列扫描,通过3D T1序列可以获得检查儿童脑灰白质宏观方面是否异常,再通过DKI序列可以获得儿童脑灰白质微观方面是否异常,对比两组儿童脑部各个区域脑灰白质是否一致,如有不同,找出其差异,为临床医师对ASD患儿早期诊断和治疗提供一个新的可能方向。 |
||||||||||||||||||||||
|
Objectives of Study: |
In this study, conventional MRI sequences, 3D T1 and DKI sequences are performed in children with ASD and age-matched normal children T1 sequence can be used to check whether the children's gray matter is abnormal in macro aspect, and then DKI sequence can be used to determine whether the micro abnormal gray matter of children's brain is abnormal. Compare whether the gray matter of each region of children's brain is consistent between the two groups. If there are differences, find out the differences, which provides a new possible direction for clinical doctors to early diagnosis and treatment of ASD children. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
对照组:2-6岁正常儿童(该组患儿为临床怀疑颅脑病变进行磁共振检查,磁共振检查结果均为正常的儿童) |
||||||||||||||||||||||
|
Inclusion criteria |
1. Control group: 2-6 years old normal children (this group of children were clinically suspected of brain disease, magnetic resonance examination results were normal children); |
||||||||||||||||||||||
|
排除标准: |
颅脑MRI检查结果诊断为除ASD疾病之外其它疾病的患儿 |
||||||||||||||||||||||
|
Exclusion criteria: |
Children with other diseases except ASD were diagnosed by MRI |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-08-01 00:00:00至 To 2023-07-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2020-08-01 00:00:00 至 To 2023-07-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
N/A |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
盲法 |
|
Blinding: |
Blind method examination |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
figshare |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
https://figshare.com |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |